Jan 30 (Reuters) - Betta Pharmaceuticals Co Ltd :
* Sees net profit for FY 2017 to decrease by 20 percent to 40 percent, compared to net profit of FY 2016 (368.8 million yuan)
* Says R&D input and increased depreciation expense as main reasons for the forecast
Source text in Chinese: goo.gl/oKPZ4a
Further company coverage: (Beijing Headline News)
 